Company

Sunovion Pharmaceuticals Inc.

Sunovion Pharmaceuticals develops and commercializes medicines for oncology, CNS disorders, and other therapeutic areas.

About

Sunovion Pharmaceuticals is headquartered in Marlborough, US, and develops and commercializes prescription medicines. Its therapeutic areas include oncology, women's health, urology, and CNS disorders; GEMTESA® is a treatment for overactive bladder. In 2008, the company reported revenue of USD 1,292.29 mn. Key executives include Adele Gulfo, Antony Loebel, Myrtle Potter, and Saburo Hamanaka.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in